Pfizer’s Covid antiviral pill may cut severe illness by 89 percent

Pfizer’s Covid antiviral pill may cut severe illness by 89 percent

The drugmaker Pfizer said Friday that clinical trials of its experimental Covid-19 pill have been so successful in preventing people from becoming hospitalized